Anticonvulsant and sleep-waking influences of riluzole in a rat model of absence epilepsy.

No abstract is available for this paper.

• Publication year

  1991

• Venue

  European Journal of Pharmacology

• Publication date

  1991-07-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0014-2999(91)90503-IPMID 1915583
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Excitatory amino acid receptors in epilepsy.

  1990cited by this paper
• Involvement of NMDA receptors in non-convulsive epilepsy in WAG/Rij rats.

  1990cited by this paper
• Riluzole, a novel antiglutamate, prevents memory loss and hippocampal neuronal damage in ischemic gerbils

  1989cited by this paper
• Riluzole, a glutamate antagonist, enhances slow wave and REM sleep in rats.

  1988cited by this paper
• Circadian rhythmicity in absence epilepsy in rats.

  1988cited by this paper
• The WAG/Rij rat model for absence epilepsy: age and sex factors.

  1987cited by this paper
• In vivo presynaptic control of dopamine release in the cat caudate nucleus--II. Facilitatory or inhibitory influence of L-glutamate.

  1986cited by this paper
• Two types of electrocortical paroxysms in an inbred strain of rats.

  1986cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--II. Biochemical properties.

  1985cited by this paper
• 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission--I. Anticonvulsant properties.

  1985cited by this paper

• Riluzole attenuates acute neural injury and reactive gliosis, hippocampal-dependent cognitive impairments and spontaneous recurrent generalized seizures in a rat model of temporal lobe epilepsy

  2024cites this paper
• An In Vivo Electroencephalographic Analysis of the Effect of Riluzole against Limbic and Absence Seizure and Comparison with Glutamate Antagonists

  2023cites this paper
• Sleep in amyotrophic lateral sclerosis: A systematic review and meta-analysis of polysomnographic findings.

  2023cites this paper
• Riluzole and novel naphthalenyl substituted aminothiazole derivatives prevent acute neural excitotoxic injury in a rat model of temporal lobe epilepsy

  2022cites this paper
• Variant-specific changes in persistent or resurgent Na+ current in SCN8A-EIEE13 iPSC-derived neurons

  2020cites this paper
• Variant-specific changes in persistent or resurgent sodium current in SCN8A-related epilepsy patient-derived neurons.

  2020cites this paper
• Prax330 reduces persistent and resurgent sodium channel currents and neuronal hyperexcitability of subiculum neurons in a mouse model of SCN8A epileptic encephalopathy.

  2019cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Amyotrophic Lateral Sclerosis

  2012cites this paper
• Sleep–wake problems in patients with amyotrophic lateral sclerosis: implications for patient management

  2012cites this paper
• Inhibition of Navβ4 Peptide-Mediated Resurgent Sodium Currents in Nav1.7 Channels by Carbamazepine, Riluzole, and Anandamide

  2011cites this paper
• The NMDA receptor complex as a therapeutic target in epilepsy: a review.

  2011cites this paper
• Recent Developments Regarding Voltage-Gated Sodium Channel Blockers for the Treatment of Inherited and Acquired Neuropathic Pain Syndromes

  2011cites this paper
• Preclinical evaluation of riluzole: assessments of ethanol self-administration and ethanol withdrawal symptoms.

  2009cites this paper
• Riluzole in the Treatment of Mood and Anxiety Disorders

  2008cites this paper
• Anti-glutamatergic effect of riluzole: comparison with valproic acid.

  2007cites this paper
• Interaction of Riluzole with the Closed Inactivated State of Kv4.3 Channels

  2006cites this paper
• Effect of riluzole on the acquisition and expression of amygdala kindling.

  2001cites this paper
• Distribution and expression of TREK-1, a two-pore-domain potassium channel, in the adult rat CNS.

  2001cites this paper
• Riluzole suppresses post‐sigh, but not spontaneous apnoeas during sleep in rats

  2001cites this paper
• The neuroprotective agent riluzole activates the two P domain K(+) channels TREK-1 and TRAAK.

  2000cites this paper
• The Neuroprotective Agent Riluzole Activates the Two P Domain K+ Channels TREK-1 and TRAAK

  2000cites this paper
• Changes in spinal cord excitability in patients affected by ulnar neuropathy

  2000cites this paper
• Ionotropic glutamate receptor modulation preferentially affects NMDA receptor expression in rat hippocampus

  2000cites this paper
• NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice.

  2000cites this paper
• Neuroreceptors and ion channels as the basis for drug action: past, present, and future.

  2000cites this paper
• Riluzole and Methylprednisolone Combined Treatment Improves Functional Recovery in Traumatic Spinal Cord Injury

  2000cites this paper
• Predicting prognosis after stroke

  2000cites this paper
• Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditions

  2000cites this paper
• Riluzole improves measures of oxidative stress following traumatic spinal cord injury.

  2000cites this paper
• Immunolocalization of the arachidonic acid and mechanosensitive baseline traak potassium channel in the nervous system.

  1999cites this paper
• A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids

  1998cites this paper
• Riluzole interacts with voltage-activated sodium and potassium currents in cultured rat cortical neurons.

  1998cites this paper
• Riluzole Does Not Attenuate Increases in Hippocampal Glutamate Concentrations in a Rabbit Model of Repeated Transient Global Cerebral Ischemia

  1998cites this paper
• [Riluzole as a treatment for amyotrophic lateral sclerosis].

  1998cites this paper
• G-proteins are involved in riluzole inhibition of high voltage-activated calcium channels in rat dorsal root ganglion neurons.

  1997cites this paper
• Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons.

  1997cites this paper
• Differential action of riluzole on tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels.

  1997cites this paper
• A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in Amyotrophic Lateral Sclerosis

  1996cites this paper
• Riluzole. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in amyotrophic lateral sclerosis.

  1996cites this paper
• The transition from slow-wave sleep to paradoxical sleep: evolving facts and concepts of the neurophysiological processes underlying the intermediate stage of sleep.

  1996cites this paper
• Excitatory amino acids in health and disease.

  1995cites this paper
• Exitatory Amino Acids in Health and Disease

  1995cites this paper
• Glutamate-induced overexpression of NMDA receptor messenger RNAs and protein triggered by activation of AMPA/kainate receptors in rat hippocampus following forebrain ischemia.

  1994cites this paper